KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ugi (UGI) Cash & Equivalents (2016 - 2025)

Ugi's Cash & Equivalents history spans 17 years, with the latest figure at $251.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 4.58% year-over-year to $251.0 million, compared with a TTM value of $251.0 million through Dec 2025, up 4.58%, and an annual FY2025 reading of $335.0 million, up 57.28% over the prior year.
  • Cash & Equivalents for Q4 2025 was $251.0 million at Ugi, down from $335.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $855.0 million in Q3 2021, with the low at $183.0 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $378.8 million, with a median of $327.5 million recorded in 2021.
  • Year-over-year, Cash & Equivalents skyrocketed 154.46% in 2021 and then tumbled 61.19% in 2023.
  • Tracing UGI's Cash & Equivalents over 5 years: stood at $334.0 million in 2021, then decreased by 5.09% to $317.0 million in 2022, then tumbled by 35.65% to $204.0 million in 2023, then grew by 17.65% to $240.0 million in 2024, then rose by 4.58% to $251.0 million in 2025.
  • Per Business Quant, the three most recent readings for UGI's Cash & Equivalents are $251.0 million (Q4 2025), $335.0 million (Q3 2025), and $350.0 million (Q2 2025).